Clinical profiles, complications, and disability in cocaine-related ischemic stroke

Pratik Bhattacharya, Sharief Taraman, Lakshmi Shankar, Seemant Chaturvedi, Ramesh Madhavan

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Cocaine use is associated with ischemic stroke through unique mechanisms, including reversible vasospasm, drug-induced arteritis, enhanced platelet aggregation, cardioembolism, and hypertensive surges. To date, no study has described disability in patients with cocaine-related ischemic stroke. The present study compared risk factors, comorbidities, complications, laboratory findings, medications, and outcomes in patients with cocaine-related (n = 41) and non-cocaine-related (n = 221) ischemic stroke (n = 147) and transient ischemic attack (n = 115) in 3 academic hospitals. The patients with cocaine-related stroke were younger (mean age, 51.9 years vs 59.1 years; P =.0008) and more likely to be smokers (95% vs 62.9%; P <.004). The prevalence of arrhythmias was significantly higher in the patients with cocaine-related stroke, and that of diabetes was significantly higher in those with non-cocaine-related strokes. The prevalence of hypertension and lipid profiles were similar in the 2 groups; however, those with cocaine-related stroke were less likely to receive statins. Antiplatelet use was similar in the 2 groups. Survivors of both groups had similar modified Rankin scores and lengths of hospital stay. In the older urban population, smoking and cocaine use may coexist with other cerebrovascular risk factors, and cocaine-related strokes have similar morbidities and mortality as non-cocaine-related strokes. Moreover, because the patients with cocaine-related stroke is younger, they have an earlier morbidity. New strategies for effective stroke prevention interventions are needed in this subgroup.

Original languageEnglish (US)
Pages (from-to)443-449
Number of pages7
JournalJournal of Stroke and Cerebrovascular Diseases
Volume20
Issue number5
DOIs
StatePublished - Sep 2011
Externally publishedYes

Fingerprint

Cocaine
Stroke
Length of Stay
Morbidity
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Arteritis
Urban Population
Transient Ischemic Attack
Platelet Aggregation
Survivors
Comorbidity
Cardiac Arrhythmias
Smoking
Hypertension
Lipids
Mortality

Keywords

  • drug abuse
  • modified Rankin scale
  • mortality
  • Stroke outcome

ASJC Scopus subject areas

  • Clinical Neurology
  • Surgery
  • Rehabilitation
  • Cardiology and Cardiovascular Medicine

Cite this

Clinical profiles, complications, and disability in cocaine-related ischemic stroke. / Bhattacharya, Pratik; Taraman, Sharief; Shankar, Lakshmi; Chaturvedi, Seemant; Madhavan, Ramesh.

In: Journal of Stroke and Cerebrovascular Diseases, Vol. 20, No. 5, 09.2011, p. 443-449.

Research output: Contribution to journalArticle

Bhattacharya, Pratik ; Taraman, Sharief ; Shankar, Lakshmi ; Chaturvedi, Seemant ; Madhavan, Ramesh. / Clinical profiles, complications, and disability in cocaine-related ischemic stroke. In: Journal of Stroke and Cerebrovascular Diseases. 2011 ; Vol. 20, No. 5. pp. 443-449.
@article{2e1a8bc53728432b9c85b63163bf3248,
title = "Clinical profiles, complications, and disability in cocaine-related ischemic stroke",
abstract = "Cocaine use is associated with ischemic stroke through unique mechanisms, including reversible vasospasm, drug-induced arteritis, enhanced platelet aggregation, cardioembolism, and hypertensive surges. To date, no study has described disability in patients with cocaine-related ischemic stroke. The present study compared risk factors, comorbidities, complications, laboratory findings, medications, and outcomes in patients with cocaine-related (n = 41) and non-cocaine-related (n = 221) ischemic stroke (n = 147) and transient ischemic attack (n = 115) in 3 academic hospitals. The patients with cocaine-related stroke were younger (mean age, 51.9 years vs 59.1 years; P =.0008) and more likely to be smokers (95{\%} vs 62.9{\%}; P <.004). The prevalence of arrhythmias was significantly higher in the patients with cocaine-related stroke, and that of diabetes was significantly higher in those with non-cocaine-related strokes. The prevalence of hypertension and lipid profiles were similar in the 2 groups; however, those with cocaine-related stroke were less likely to receive statins. Antiplatelet use was similar in the 2 groups. Survivors of both groups had similar modified Rankin scores and lengths of hospital stay. In the older urban population, smoking and cocaine use may coexist with other cerebrovascular risk factors, and cocaine-related strokes have similar morbidities and mortality as non-cocaine-related strokes. Moreover, because the patients with cocaine-related stroke is younger, they have an earlier morbidity. New strategies for effective stroke prevention interventions are needed in this subgroup.",
keywords = "drug abuse, modified Rankin scale, mortality, Stroke outcome",
author = "Pratik Bhattacharya and Sharief Taraman and Lakshmi Shankar and Seemant Chaturvedi and Ramesh Madhavan",
year = "2011",
month = "9",
doi = "10.1016/j.jstrokecerebrovasdis.2010.02.017",
language = "English (US)",
volume = "20",
pages = "443--449",
journal = "Journal of Stroke and Cerebrovascular Diseases",
issn = "1052-3057",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - Clinical profiles, complications, and disability in cocaine-related ischemic stroke

AU - Bhattacharya, Pratik

AU - Taraman, Sharief

AU - Shankar, Lakshmi

AU - Chaturvedi, Seemant

AU - Madhavan, Ramesh

PY - 2011/9

Y1 - 2011/9

N2 - Cocaine use is associated with ischemic stroke through unique mechanisms, including reversible vasospasm, drug-induced arteritis, enhanced platelet aggregation, cardioembolism, and hypertensive surges. To date, no study has described disability in patients with cocaine-related ischemic stroke. The present study compared risk factors, comorbidities, complications, laboratory findings, medications, and outcomes in patients with cocaine-related (n = 41) and non-cocaine-related (n = 221) ischemic stroke (n = 147) and transient ischemic attack (n = 115) in 3 academic hospitals. The patients with cocaine-related stroke were younger (mean age, 51.9 years vs 59.1 years; P =.0008) and more likely to be smokers (95% vs 62.9%; P <.004). The prevalence of arrhythmias was significantly higher in the patients with cocaine-related stroke, and that of diabetes was significantly higher in those with non-cocaine-related strokes. The prevalence of hypertension and lipid profiles were similar in the 2 groups; however, those with cocaine-related stroke were less likely to receive statins. Antiplatelet use was similar in the 2 groups. Survivors of both groups had similar modified Rankin scores and lengths of hospital stay. In the older urban population, smoking and cocaine use may coexist with other cerebrovascular risk factors, and cocaine-related strokes have similar morbidities and mortality as non-cocaine-related strokes. Moreover, because the patients with cocaine-related stroke is younger, they have an earlier morbidity. New strategies for effective stroke prevention interventions are needed in this subgroup.

AB - Cocaine use is associated with ischemic stroke through unique mechanisms, including reversible vasospasm, drug-induced arteritis, enhanced platelet aggregation, cardioembolism, and hypertensive surges. To date, no study has described disability in patients with cocaine-related ischemic stroke. The present study compared risk factors, comorbidities, complications, laboratory findings, medications, and outcomes in patients with cocaine-related (n = 41) and non-cocaine-related (n = 221) ischemic stroke (n = 147) and transient ischemic attack (n = 115) in 3 academic hospitals. The patients with cocaine-related stroke were younger (mean age, 51.9 years vs 59.1 years; P =.0008) and more likely to be smokers (95% vs 62.9%; P <.004). The prevalence of arrhythmias was significantly higher in the patients with cocaine-related stroke, and that of diabetes was significantly higher in those with non-cocaine-related strokes. The prevalence of hypertension and lipid profiles were similar in the 2 groups; however, those with cocaine-related stroke were less likely to receive statins. Antiplatelet use was similar in the 2 groups. Survivors of both groups had similar modified Rankin scores and lengths of hospital stay. In the older urban population, smoking and cocaine use may coexist with other cerebrovascular risk factors, and cocaine-related strokes have similar morbidities and mortality as non-cocaine-related strokes. Moreover, because the patients with cocaine-related stroke is younger, they have an earlier morbidity. New strategies for effective stroke prevention interventions are needed in this subgroup.

KW - drug abuse

KW - modified Rankin scale

KW - mortality

KW - Stroke outcome

UR - http://www.scopus.com/inward/record.url?scp=80052508029&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052508029&partnerID=8YFLogxK

U2 - 10.1016/j.jstrokecerebrovasdis.2010.02.017

DO - 10.1016/j.jstrokecerebrovasdis.2010.02.017

M3 - Article

VL - 20

SP - 443

EP - 449

JO - Journal of Stroke and Cerebrovascular Diseases

JF - Journal of Stroke and Cerebrovascular Diseases

SN - 1052-3057

IS - 5

ER -